240 completed, 49 unknown, 36 recruiting, 27 active not recruiting. 72 Not applicable, 72 Phase 3, 43 Phase 2, 30 Phase 4, 17 Phase 1.
Follow Psoriatic Arthritis: new trials by email Literature Review of Psoriatic Arthritis trials Research Report on Psoriatic Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt) Placebo, Zasocitinib - Psoriatic Arthritis | Phase 3 | Not yet recruiting | Takeda | 644 | 2027-01-11 | 2026-10-13 |
| Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers Deucravacitinib - Systemic Lupus Erythematosus, Sjögren's Disease | Phase 3 | Not yet recruiting | Bristol-Myers Squibb | 2300 | 2026-12-31 | 2026-09-03 |
| Apremilast and Adalimumab in Psoriatic Arthritis Patients Adalimumab, Apremilast - Psoriatic Arthritis, Ultrasound Assessment | Not applicable | Not yet recruiting | Tanta University | 60 | 2026-12-30 | 2026-09-08 |
| Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients Meibomian Gland Dysfunction, Dry Eye Syndromes | Not yet recruiting | Assiut University | 150 | 2026-10-01 | 2026-09-09 | |
| Disease Impact and Its Correlation With Disease Activity in Psoriatic Arthritis Psoriatic Arthritis | Not yet recruiting | Assiut University | 80 | 2026-10-01 | 2026-08-31 | |
| Ultrasound and Shear Wave Elastography Assessment of Entheses in Psoriatic Arthritis Grayscale Ultrasonography, Power Doppler Ultrasonography, and Shear Wave Elastography - Psoriatic Arthritis, Enthesitis | Not yet recruiting | Marmara University | 60 | 2026-07-27 | 2026-08-25 | |
| A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis TQH3906 Capsule, TQH3906 Placebo Capsule, Tofacitinib Citrate Tablet 5 mg - Psoriatic Arthritis | Phase 2 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 156 | 2026-07-16 | 2026-09-02 |
| Transcutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) - Psoriatic Arthritis | Not applicable | Recruiting | Marmara University | 15 | 2026-06-02 | 2026-06-17 |
| Inflammation Digital Biomarkers Validation Study Psoriatic Arthritis, Psoriasis (PsO) | Not yet recruiting | University of Oxford | 3458 | 2026-06-01 | 2026-05-22 | |
| CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry Tirzepatide - Psoriatic Arthritis, Osteoarthitis | Not yet recruiting | JULIO GRANADOS MONTIEL | 30 | 2026-05-01 | 2026-05-12 | |
| Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) Tulisokibart, Placebo - Psoriatic Arthritis | Phase 2 | Active not recruiting | Merck Sharp & Dohme LLC | 140 | 2026-04-20 | 2026-10-20 |
| Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis Zasocitinib - Psoriatic Arthritis | Phase 3 | Recruiting | Takeda | 1182 | 2026-03-11 | 2026-09-09 |
| Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis Active Repetitive Transcranial Magnetic Stimulation (rTMS), Control Repetitive Transcranial Magnetic Stimulation (rTMS) - Psoriatic Arthritis | Not applicable | Not yet recruiting | NHS Greater Glasgow and Clyde | 40 | 2026-03-01 | 2026-02-11 |
| Combined High-Intensity Aerobic Training and Resistance Training in Psoriatic Arthritis Exercise program - Psoriatic Arthritis | Not applicable | Not yet recruiting | Vastra Gotaland Region | 88 | 2026-02-02 | 2026-01-22 |
| Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases Rheumatoid Arthritis (RA, Ankylosing Spondylitis | Not yet recruiting | Bursa City Hospital | 300 | 2026-01-15 | 2026-01-09 | |
| A Study of Picankibart in Patients With Active Psoriatic Arthritis Placebo, Picankibart - Psoriatic Arthritis | Phase 2 / Phase 3 | Recruiting | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 222 | 2025-12-18 | 2026-03-20 |
| A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults Bimekizumab regimen 1 iv, Bimekizumab regimen 2 iv, Bimekizumab regimen 3 sc - Psoriatic Arthritis, Axial Spondyloarthritis | Phase 1 | Recruiting | UCB Biopharma SRL | 392 | 2025-12-10 | 2026-07-06 |
| Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders Creating Health Online Course, Delayed access to Creating Health Online Course - Rheumatoid Arthritis, Sjogren's Syndrome | Not applicable | Recruiting | Terry L. Wahls | 400 | 2025-12-01 | 2026-08-10 |
| A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) Bimekizumab - Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Phase 1 | Recruiting | UCB Biopharma SRL | 20 | 2025-11-05 | 2026-09-18 |
| Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis Ultrasound Stimulation, Non-active ultrasound stimulation - Psoriatic Arthritis, Rheumatoid Arthritis | Not applicable | Completed | Surf Therapeutics | 16 | 2025-10-01 | 2026-01-07 |
Showing 20 of 402. Sign in to see all of them.
Arthritis, Psoriatic (402) · Arthritis, Rheumatoid (120) · Psoriasis (77) · Spondylitis, Ankylosing (69) · Arthritis (35) · Crohn Disease (32) · Spondylarthritis (25) · Axial Spondyloarthritis (23) · Colitis, Ulcerative (23) · Lupus Erythematosus, Systemic (19) · Sjogren's Syndrome (13) · Autoimmune Diseases (10) · Inflammation (10) · Obesity (10) · Inflammatory Bowel Diseases (9)
Bone Diseases (402) · Skin Diseases, Papulosquamous (402) · Skin and Connective Tissue Diseases (402) · Spinal Diseases (402) · Musculoskeletal Diseases (399) · Joint Diseases (397) · Skin Diseases (396) · Spondylitis (396) · Spondylarthropathies (393) · Spondylarthritis (377) · Arthritis (367) · Psoriasis (325) · Immune System Diseases (127) · Connective Tissue Diseases (125) · Rheumatic Diseases (120)
Adalimumab (30) · secukinumab (29) · Etanercept (20) · Methotrexate (18) · apremilast (17) · bimekizumab (13) · golimumab (11) · Ustekinumab (10) · tofacitinib (10) · Infliximab (9) · ixekizumab (9) · Certolizumab Pegol (7) · Surveys and Questionnaires (7) · upadacitinib (7) · Abatacept (6)
AbbVie (20) · Novartis Pharmaceuticals (19) · Amgen (13) · Pfizer (12) · UCB Biopharma SRL (12) · University of Oxford (9) · AbbVie (prior sponsor, Abbott) (8) · Bristol-Myers Squibb (7) · University of Pennsylvania (7) · Abbott (6) · Diakonhjemmet Hospital (6) · Eli Lilly and Company (6) · Bezmialem Vakif University (5) · Takeda (5) · Brigham and Women's Hospital (4)
United States (126) · Germany (72) · Canada (69) · United Kingdom (69) · France (62) · Poland (59) · Spain (59) · Czechia (53) · Russia (41) · Australia (39) · Hungary (39) · Italy (39) · Belgium (34) · Bulgaria (31) · China (24)
Eisa Mohammed Hegazy, Professor (3) · Lihi Eder, MD, PhD (3) · Abhishek Abhishek (2) · Alexis Ogdie-Beatty, MD (2)
PMID 37316690, PMID 38446397, PMID 40194794, PMID 41807031, PMID 39120849, PMID 30018799, PMID 31077258, PMID 31203228, PMID 31909868, PMID 34536218, PMID 34795065, PMID 35393269, PMID 38488975, PMID 38754125, PMID 39215949, PMID 39534481, PMID 40241921, PMID 40347389, PMID 41381988, PMID 41838419, PMID 42152504, PMID 42386286, PMID 42860055, PMID 25593233, PMID 29045207, PMID 29045212, PMID 30373651, PMID 30414064, PMID 30680661, PMID 31111255, PMID 31112005, PMID 31801620, PMID 31964419, PMID 32006348, PMID 32816215, PMID 32910531, PMID 33766074, PMID 34226183, PMID 34260044, PMID 34464029, PMID 34510295, PMID 34864911, PMID 34870800, PMID 34921355, PMID 34970731, PMID 35139908, PMID 35385361, PMID 35544084, PMID 35606663, PMID 35789257
2016 (10), 2017 (7), 2018 (6), 2023 (6), 2014 (5), 2015 (5), 2019 (4), 2025 (3), 2005 (2), K08CA237619 (1), P20GM130414 (1), P60AR047782 (1), R01AR069000 (1), RC2AR058986 (1), UM1CA186688 (1)